"L-Selectin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell adhesion molecule and CD antigen that serves as a homing receptor for lymphocytes to lymph node high endothelial venules.
| Descriptor ID |
D019041
|
| MeSH Number(s) |
D12.776.395.550.200.625.903 D12.776.395.550.200.700.510 D12.776.503.843.510 D12.776.543.550.200.625.903 D12.776.543.550.200.700.510 D12.776.543.750.705.877.903 D23.050.301.350.625.903 D23.050.301.350.700.510
|
| Concept/Terms |
L-Selectin- L-Selectin
- Mel-14 Antigen
- Antigen, Mel-14
- Mel 14 Antigen
- L Selectin
- Selectin, L
- LAM-1
- CD62L Antigens
- Leu-8 Antigen
- Antigen, Leu-8
- Leu 8 Antigen
- TQ1 Antigen
- Antigen, TQ1
- CD62L Antigen
- Antigen, CD62L
- Antigens, CD62L
- Leukocyte Adhesion Molecule, LAM-1
- Leukocyte Adhesion Molecule, LAM 1
- LECAM-1
|
Below are MeSH descriptors whose meaning is more general than "L-Selectin".
Below are MeSH descriptors whose meaning is more specific than "L-Selectin".
This graph shows the total number of publications written about "L-Selectin" by people in this website by year, and whether "L-Selectin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 4 | 4 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "L-Selectin" by people in Profiles.
-
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells. J Biol Chem. 2019 06 07; 294(23):9198-9212.
-
Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function. Cancer Immunol Res. 2017 08; 5(8):666-675.
-
Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control. Oncotarget. 2016 Oct 25; 7(43):69371-69383.
-
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. 2018 02; 67(2):320-332.
-
Facile supermolecular aptamer inhibitors of L-selectin. PLoS One. 2015; 10(3):e0123034.
-
A novel Cd8-cis-regulatory element preferentially directs expression in CD44hiCD62L+ CD8+ T cells and in CD8aa+ dendritic cells. J Leukoc Biol. 2015 Apr; 97(4):635-44.
-
Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients. Anticancer Res. 2011 Dec; 31(12):4099-109.
-
A human memory T cell subset with stem cell-like properties. Nat Med. 2011 Sep 18; 17(10):1290-7.
-
The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions. Breast Cancer Res. 2011 Aug 16; 13(4):R81.
-
Adam17-dependent shedding limits early neutrophil influx but does not alter early monocyte recruitment to inflammatory sites. Blood. 2011 Jul 21; 118(3):786-94.